Related Experiment Video
Updated: Aug 31, 2025

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
Co-isolates of Acinetobacter baumannii complex in polymicrobial infections: a meta-analysis
Stamatis Karakonstantis1,2, Petros Ioannou1, Evangelos I Kritsotakis2,3
1Department of Internal Medicine, Infectious Diseases, University Hospital of Heraklion, Heraklion, Crete, Greece.
Abstract:
Background. Acinetobacter baumannii complex (ABC) infections are commonly polymicrobial. Examining which pathogens are most commonly co-isolated with ABC is an important first step for assessing disease potential due to pathogen-pathogen interactions. Methods. Based on a systematic search of PubMed, Scopus and CENTRAL, we estimated percent proportions of co-isolates in polymicrobial pulmonary and bloodstream ABC infections using random-effects meta-analysis.
Results:
Twenty-eight eligible studies were analysed reporting 575 polymicrobial bloodstream and 290 polymicrobial pulmonary infections. Common co-isolates in pulmonary infections were P. aeruginosa (36%, 95% CI 24-49%, I2 71%), S. aureus (28%, 95% CI 19-38%, I2 44%) and Klebsiella spp. (11%, 95% CI 6-20 %, I2 56%), while the prevalence of other co-pathogens did not exceed 5%. Most common co-isolates in bloodstream infections were coagulase-negative Staphylococci (21%, 95% CI 12-34 %, I2 84%), Enterococci (15%, 95% CI 9-26%, I2 73%), P. aeruginosa (12%, 95% CI 6-22%, I2 74%), Klebsiella spp. (10%, 95% CI 6-16%, I2 42%), Enterobacter spp. (10%, 95% CI 6-16 %, I2 38%) and S. aureus (8%, 95% CI 4-15%, I2 58%).
Conclusion:
The common co-isolation of certain pathogens (especially P. aeruginosa ) with ABC suggests potential beneficial between-pathogen interactions, which may have treatment implications for polymicrobial infections and requires further study.
More Related Videos
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Acute Pyelonephritis II: Diagnostic Studies and Management
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Antibiotic Selection

